MedTrace Logo

Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

NCT00753116 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-11-06

No results posted yet for this study

Summary

The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.

Conditions

  • Kidney Failure, Chronic
  • Renal Dialysis

Interventions

DEVICE

Renal Denervation with a catheter-based procedure

Disruption of the renal nerves with a catheter-based procedure

Sponsors & Collaborators

  • Medtronic Vascular

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2008-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00753116 on ClinicalTrials.gov